RecruitingNCT07599904

REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)

Sponsor

Medtronic Neurovascular Clinical Affairs

Enrollment

1,500 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Post-Market Registry

Min Age: 18 Years

Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device* during treatment for acute ischemic stroke.
Participant is 18 years of age or older.

Participant who may be unable to complete follow-up within the registry.
Participant of child-bearing potential who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
Participant is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results based on Principal Investigator's discretion.

Interested in this trial?

Get notified about updates and connect with the research team.

PROCEDUREDevice: Mechanical Thrombectomy

Index stroke procedure and follow-up visits up to 90 days post index procedure

Buffalo General Medical Center

Buffalo, New York, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

NCT07599904